TORONTO, April 2, 2018 /CNW/ - GeneNews Limited
("GeneNews" or the "Company") (TSX:GEN) today announced that it
will release its Fourth Quarter and Full Year 2017 financial
results before markets open on Tuesday,
April 3, 2017
GeneNews' Chairman and CEO, James R.
Howard-Tripp, will host a conference call at 8:30 a.m. ET to review the financial results and
discuss business developments during the period.
Fourth Quarter and Full Year 2017 Results Conference Call
Details:
Date:
|
April 3,
2018
|
|
|
Time:
|
8:30 a.m.
ET
|
|
|
Live
Call:
|
1- 888-231-8191
(Canada and the United States)
|
|
|
|
1-647-427-7450
(International)
|
|
|
Conference
ID:
|
1781536
|
|
|
Replay:
|
1-855-859-2056
(Canada and the United States)
|
|
|
|
1-416-849-0833
(International)
|
|
|
Password:
|
1781536
|
The call will also be broadcast live and archived on the
Company's website at www.GeneNews.com in the Investor's
section.
About GeneNews
GeneNews, an innovator in the liquid biopsy space, is committed
to becoming a leader in advanced diagnostics and personalized
medicine, serving as a strong commercialization outlet for early
detection of cancer and other chronic diseases. Our mission is to
identify, assess and make commercially available a comprehensive
menu of diagnostics that provide physicians and patients with
personalized clinical intelligence and actionable information to
improve health outcomes through the early diagnosis of disease. Our
Richmond, Virginia-based
Innovative Diagnostic Laboratory clinical reference lab specializes
in traditional and advanced clinical evidence-based blood testing
that helps find, understand, and address cancer risk in patient
populations. Currently, IDL offers risk assessment blood tests for
four prevalent cancer types - colon, lung, prostate and breast.
GeneNews' common shares trade on the Toronto Stock Exchange under
the symbol 'GEN'. More information on GeneNews and IDL can be found
at www.GeneNews.com and www.myinnovativelab.com,
respectively.
Forward-Looking Statements
This press release contains forward-looking statements
identified by words such as "expects", "will" and similar
expressions, which reflect the Corporation's current expectations
regarding future events. The forward-looking statements involve
risks and uncertainties that could cause the Corporation's actual
events to differ materially from those projected herein. Investors
should consult the Corporation's ongoing quarterly filings and
annual reports for additional information on risks and
uncertainties relating to these forward-looking statements. The
reader is cautioned not to rely on these forward-looking
statements. The Corporation disclaims any obligation to update
these forward-looking statements, except as required by law.
SOURCE GeneNews Limited